GUIDELINES TO AUTHOURS ON SUBMISSION OF ABSTRACTS FOR THE INTERNATIONAL CONFERENCE ON HEPATOBILIARY AND HAEMATOLYMPHOID PATHOLOGY 2013

The presentations will be in the format of poster presentations only. Abstracts should be case reports/case series or research inHepatobiliary, Pancreatic or haematolymphoid Pathology or related specialities only.The abstracts should conform to the following requirements.

  1. The presenting author is required to register once the abstract has been accepted by the scientific committee. Underline the name of the presenting author. The corresponding author should sign the abstract form.
  2. Please use the abstract form annexed. Begin the text of the abstract without indentation using double spacing. Use A4 sized papers with margins at 30mm all round. Five copies should be submitted (the original and four clear photocopies are acceptable) with a soft copy. Please ensure that abstract do not include graphs, tables or references.
  3. The abstracts will be reviewed anonymously by referees. The corresponding author will be informed of the results by on or before 15th of June 2013.
  4. All abstract should reach the Coordinators/ SecretariesICON Hepatobiliary Pancreatic & Haematolymphoid Pathology 2013, College of Pathologists of Sri Lanka before 15.00Hr on 31st of May 2013. Late entries will not be accepted.
  5. The title of the abstract should be brief but adequately descriptive. The College of Pathologists reserves the right to modify the title where necessary.
  6. Author’s surname should be preceded by the initial(s) or forename(s), but not by prefix such as Mr, Dr or Professor. The institution(s) where the work was performed should be stated. The names of authors and place of work should be mentioned on the original and on one copy. The names of the authors and place of work should not appear on other three copies. (These three copies will be sent for anonymous review)
  7. The abstract should also be submitted to the collage as an attachment (the college email address is ).
  8. The text of the abstract should not exceed 250 words. It should be structured as follows in case /case series presentation:
  9. Short Clinical History
  10. Gross Pathology
  11. Microscopic Pathology
  12. Discussion
  13. Comments/Conclusions

OR in case of research

  1. Objectives
  2. Design, setting and method (including statistical methods where relevant)
  3. Results
  4. Conclusions
  1. Presenting authors are requested to refer to the abstract papers for case reports in a recent issue of the CMJ, BMJ or Annals of Internal Medicine for further guidance on writing abstracts.
  2. The authors should take the public responsibility for the case studies and the contents reported.
  3. If the work has been previously presented or published in whole or part this should be stated clearly in the abstract. This does not disqualify an abstract but must be stated when submitting the paper.
  4. Acknowledgements in the abstract should be confined to citing similar presentations/ publications.
  5. The College reserves the right to make alterations and to edit text to improve presentation.
  6. Abstracts not conforming to the above instructions will be rejected. Accepted abstract will be published in the book of abstracts.
  7. All “intervention” research studies should be supported by a photocopy of a letter granting approval from an acceptable Ethical Review Committee (ERC) obtained before healthy volunteers or patients were recruited for the study. “Intervention “ studies on human participants are those involving trails of new treatment (medical, surgical, dietary, physical, rehabilitationetc); withholding or modifying accepted treatment, or anonymous self administrated /face-to-face interviews on health or health related matters for purposes of research. In addition to ERC approval, the study guarantors should certify that voluntary informed consentwas obtained from all participants (or their guardians in cases of studies involving minors, institutionalized people etc), in cases of studies. Abstracts of “intervention” studies not conforming to these ethical criteria will be rejected.
  1. The abstracts forwarded will be considered for presentation after assessment

by the College.

For further details please contact:

The Editors/ Coordinators/ SecretariesICON Hepatobiliary Pancreatic & Haematolymphoid Pathology 2013

College of Pathologists of Sri Lanka

No6, Wijerama Mawatha,

Colombo 7.

Email:

Tel: 94112685088

Secretaries: Dr. A .A. H. Priyani 94718609027

Dr. Saumya K Liyanage 94712088710

Coordinator: Dr Mangala Bopagoda 94 715344032

Annex 1No: ………………….

  1. Authors (Underline the name of the presenting author ):
  1. Institution(s) where work was done:
  1. Corresponding Author:
  2. Name:
  3. Address:
  1. Email address:
  2. Telephone:
  3. Mobile:
  4. Office:
  5. Residence:
  1. Title of paper:
  1. Has the presenting author registered for the sessions: Yes/ No
  1. What is the word count: (Should not be more than 250 words)
  1. Has the case report been presented elsewhere or published : Yes/ No

If yes, give details:

  1. Is Ethical review Committee approval letter in “Intervention studies” attached?

Date: ……………………………………Signature: ………………………………….

For Office Use Only

1 / Is the abstract less than 250 words / YES / NO
2 / Is it structured as requested? / YES / NO
3 / Names of author, place of work not mentioned in 3 copies / YES / NO
4 / Floppy diskette or CD available / YES / NO
5 / Has the presenting author registered / YES / NO

Abstract form

Please type double spaced. Use capital letters only for first letter of proper nouns and of sentences. Abstract must be structured whenever possible, and have 250 words or less. Fivecopies to be submitted. (Names of authors should not appear in 3 copies):

Title:…………………………………………………….

Abstract ((State number of words: ………….)